Shoreline Biosciences
Developing clinically effective immunotherapies using intelligently engineered iPSC-derived allogeneic cells. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD865m—1.3b (Dealroom.co estimates Nov 2021.)
San Diego California (HQ)
Authorizing premium user...